Pediatric Crohn ' s: Adalimumab+Methotrexate Offers Strong Benefit Pediatric Crohn ' s: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn ' s disease who are starting adalimumab.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
More News: Children | Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Humira | Inflammatory Bowel Disease | Methotrexate | Pediatrics